簡介:達(dá)比加群,Dabigatran是可逆的高活性直接凝血酶抑制劑(DTI),Ki為4.5 nM。
達(dá)比加群物理化學(xué)性質(zhì):
密度 |
1.4±0.1 g/cm3 |
沸點 |
797.1±70.0 °C at 760 mmHg |
熔點 |
268-272oC |
分子式 |
C25H25N7O3 |
分子量 |
471.511 |
閃點 |
435.9±35.7 °C |
精確質(zhì)量 |
471.201874 |
PSA |
150.22 |
LogP |
0.79 |
外觀性狀 |
黃褐色固體 |
蒸汽壓 |
0.0±2.9 mmHg at 25°C |
折射率 |
1.694 |
儲存條件 |
Refrigerator, Under Inert Atmosphere |
達(dá)比加群詳細(xì)介紹:
中文名稱: |
達(dá)比加群 |
中文別名: |
達(dá)比加群;N-[[2-[[[4-(氨基亞氨基甲基)苯基]氨基]甲基]-1-甲基-1H-苯并[D]咪唑-5-基]羰基]-N-吡啶-2-基-BETA-丙氨酸;4-(4-(4-硝基苯基)-1-哌嗪基)苯酚;Dabigatran (BIBR 953) 抑制劑;N-[[2-[[[4-(氨咪甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-2-吡啶基-β-丙氨酸;達(dá)比加群-D4;達(dá)比加群標(biāo)準(zhǔn)品;達(dá)比加群雜質(zhì);達(dá)比加群酯;達(dá)比加群酯雜質(zhì)A;尾-Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carb... |
英文名稱: |
3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methyl-benzoimidazole-5-carbonyl]-pyridin-2-yl-amino]propanoic acid |
英文別名: |
3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methyl-benzoimidazole-5-carbonyl]-pyridin-2-yl-amino]propanoic acid;BIB-953;BIBR 953;Dabigatran;BIBR 953ZW;BIBR 953(Dabigatran);Dabigatran (BIBR 953);Dabigatran Etexilate Mesilate;BIBR 953 (Dabigatran, Pradaxa);3-[[2-[[(4-carbaMiMidoylphenyl)aMino]Methyl]-1-Met;N- (2-{ (4-carbaMiMidoylphenyl)aMino Methyl}-1-Met;3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid;β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-;N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-Alanine;BIBR 953,Dabigatran,BIBR953;BIBR-953;UNII-I0VM4M70GC;3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid |
CAS號: |
211914-51-1 |
分子式: |
C25H25N7O3 |
分子量: |
471.51 |
詳細(xì)描述: |
博飛美科提供211914-51-1,達(dá)比加群,BIBR 953 (Dabigatran, Pradaxa),Perfemiker,上?,F(xiàn)貨。 Perfemiker,致力于提供高品質(zhì)、高性價比小分子化合物的產(chǎn)品。 Perfemiker小分子化合物大量庫存,提供超過2萬種的抑制劑、激動劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 強效的、可逆的直接凝血酶抑制劑,Dabigatran(BIB-953; BIBR 953ZW)是可逆的高活性直接凝血酶抑制劑(DTI),Ki為4.5 nM。 查詢關(guān)鍵詞:“211914-51-1,達(dá)比加群,BIBR 953 (Dabigatran, Pradaxa),Perfemiker,上海現(xiàn)貨”。 |
達(dá)比加群參考文獻(xiàn):
[1]. Wienen W, Stassen JM, Priepke H, In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally activeprodrug, dabigatran etexilate. Thromb Haemost. 2007 Jul;98(1):155-62.
[2]. Kansal AR, Sorensen SV, Gani R, Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients withatrial fibrillation. Heart. 2012 Apr;98(7):573-8.